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Introduction
The brain is the most complex and dynamically organized
organ with a high level of computational ability that
enables the acquisition and integration of information in
order to generate appropriate responses to environmental
and physiological inputs. Pivotal to its function is its
extensive neuronal connectivity, due in particular to the
1015 synaptic connections of the 100 billion central
neurons of the human brain, via which chemical neuro-
transmission occurs. In brief, an action potential travels
along the axon and reaches the presynaptic bouton, causing
the neurotransmitter-containing synaptic vesicles to fuse
with the membrane in the active zone. The released
transmitter diffuses through the synaptic cleft, binds to the
corresponding receptors and causes ion influx into the
dendritic spine that ultimately drives neuronal activity. In
nearly all neurons, both short- and long-term plastic
changes can take place. Depending on the preceding
neuronal activity, the synaptic strength can be enhanced or
depressed; this is underpinned by molecular changes in the
synapse, including alterations of protein expression pat-
tern, post-translational modifications and protein interact-
ing with partners.
With the advancement of proteomics technology, it is now
possible to define the whole protein constituent of the
synapse. Proteome analyses of synaptosome, synaptic
membrane and pre- and post-synaptic compartments of the
glutamatergic synapse revealed a surprisingly high complex-
ity in the synapse, which possibly contains thousands of
distinct proteins. Recent studies further revealed that protein
phosphorylation is a common event in the synapse, which is
consistent with the presence of diverse classes of kinases and
phosphatases in the synapse. Quantitative synaptic proteo-
mics is essential for deciphering the molecular changes in the
synapse. Several laboratories are initiating this technically
demanding task, and I anticipate that it will be a major
research line in the coming years.
Technologies for synaptic proteomics
Synaptic proteomics analysis requires, first of all, the
purification of subcellular organelles from the brain regions
of interest. The isolation of synaptosome, synaptic mem-
brane and synaptic subdomains such as post-synaptic
density (PSD) is well-established. Generally, multiple steps
of discontinuous density gradient ultra-centrifugation are
employed to enrich the distinct organelles. In special cases
where high spatial resolution are needed—for example, in
the proteomics analysis of neurofibrillary tangles in
Alzheimer disease [1]—laser capture microdissection has
been employed to collect the samples. To reveal the protein
interaction networks in the synapse, a number of multi-
protein complexes, including NMDA receptor and AMPA
receptor protein complexes [2], have been isolated by
means of peptide- and antibody-based affinity purification.
Contaminants are often present in the samples, and they
need to be taken into account when interpreting the
proteomics data.
All current proteomics methodologies have been used to
analyze the proteomes of synapse and synaptic subdomains.
Gel-based proteomics
SDS polyacrylamide gel electrophoresis and mass spec-
trometry The first proteomics study used SDS gel
electrophoresis to separate PSD proteins. Proteins were
characterized based on the peptide mass fingerprint
generated from the tryptic digests of each protein band.
This approach is useful for the analysis of a single protein
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or (at the most) a few proteins per protein band. In this
early study about 30 proteins were characterized [3].
In order to address the limitations of peptide mass
fingerprint analysis, recent studies have introduced one or
two sequential liquid chromatography (LC) step(s) in
order to separate the tryptic peptides, followed by tandem
mass spectrometry (MS/MS) for structural characteriza-
tion. This approach identified 10–20 times as many
proteins [4, 5]. Isotope-coded reagents (ICAT) and
AQUA peptides (see below for methodology) were used
to quantify the samples [5].
Two-dimensional gel electrophoresis and mass spectrom-
etry Two-dimensional gel electrophoresis has been used to
separate and quantify proteins, including post-translational
modified forms, from synaptic structures [6]. Proteins spots
were characterized by (tandem) mass spectrometry. A
disadvantage of 2-D gel is that it has only limited ability to
fractionate hydrophobic proteins, proteins larger than
100 kDa, and very basic and acidic proteins. Consequently,
many major players in synapse physiology, such as receptors
and ion channels, which are generally large proteins contain-
ing many trans-membrane domains, cannot be analyzed.
Gel-free proteomics
The most commonly used gel-free proteomics consists of
tryptic digest of the synaptic proteome, separation of the
peptides by two or more LC steps, and characterization of
the peptides with MS/MS. Using this approach, several
hundreds to over a thousand synaptic proteins have been
described [7, 8]. Post-translational modified peptides can
also be characterized using this approach. Generally, an
extra chromatography step is incorporated to isolate the
post-translational modified peptides; for example, immo-
bilized metal affinity chromatography (IMAC) is widely
used for the enrichment of phosphopeptides [7, 9].
Three approaches have been used for quantitative
synaptic proteomics: the isotope-coded affinity tag
(ICAT), isobaric tags for relative and absolute quantitation
(iTRAQ), and absolute quantification (AQUA) strategies.
Protein AQUAA known amount of a set of isotope-labeled
synthetic peptides that correspond exactly to the selected
tryptic peptides of the proteins contained in a sample will
be mixed with the sample, separated and mass spectro-
metrically analyzed together. The synthetic peptides serve
as an internal standard. The quantity of native peptides can
be calculated using mass spectrometric peak ratios. A very
large number of isotope labeled peptides will have to be
synthesized to quantify the synapse proteome.
ICAT The cysteine residues of the proteins are tagged with
ICAT reagents. There are two ICAT reagents, the heavy
and light versions that differ in mass by 9 Da. One sample
is labeled with ICAT heavy reagent, and the other sample
with ICAT light reagent. The two samples are then mixed
together, digested, and the ICAT-tagged peptides affinity-
isolated by an avidin column. The mass spectrometric
peak ratio of a peptide tagged with light and heavy ICAT
reagents from the two samples, respectively, reveals the
relative expression level of the corresponding protein.
Obviously, proteins that do not contain cysteine residue
will not be detected.
iTRAQ iTRAQ reagents are a multiplexed set of four
isobaric reagents that are identical in mass. Tryptic
peptides from up to four samples can be tagged with the
four isobaric reagents respectively in a single experiment.
Upon the collision-induced dissociation of a tagged
peptide, signature ions will be produced for each iTRAQ
reagent. The peak ratios of the four iTRAQ signature ions
represent the relative quantities of this peptide contained in
the four samples. As quantitation is coupled to MS/MS
analysis of the peptides, the analysis of a sample of high
protein complexity may be difficult due to the high
demands placed on precursor ion selection in order to
avoid the overlapping of the same signature ions produced
from distinct peptides of similar masses eluting in the
same LC fractions. Furthermore, a large number of MS/MS
analyses will have to be performed. In a typical experi-
ment, the abundant proteins are preferentially selected for
analysis. Therefore, proteins at lower expression levels
may be missed.
The proteomes of the synapse and synaptic subdomains
Post-synaptic density
In the past three years, many publications have reported the
characterization of the proteome of PSD [2, 4–8, 10, 11].
The number of proteins identified have ranged from around
a hundred to over a thousand. In general, proteins identified
from PSD preparation can be classified into a number of
functional groups: groups including ion channels and
adhesion molecules, the scaffold and signaling protein
complexes and the receptors, proteins of the cytoskeleton
and their interacting partners for the maintenance and
modulation of synaptic architecture, proteins involved in
sorting and trafficking of membrane proteins, components
for energy supply, the proteasome system for specific
synaptic protein degradation, the chaperone system for
correct protein folding and the local protein synthetic
machinery. This is consistent with our knowledge that PSD
is one of the most complicated subcellular structures in the
cell and furthermore appears to have the capacity to
function in a (semi-)autonomous manner.
Although a large number of proteins have been
identified from PSD fractions, it should be realized that
not all of these proteins are contained in each PSD. First,
excitatory synapses are extremely heterogeneous in nature.
The proteins identified may represent the sum of the
proteins present in PSD from all synapses in the brain
region under study. Second, the biochemical isolation
procedure merely enriches the organelle of interest, i.e. the
PSD preparation may contain a considerable amount of
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contaminants. To address this problem, ICAT-based corre-
lation profiling has been carried out on PSD proteins and
synaptic membrane proteins [12]. As expected, core PSD
proteins such as glutamate receptors and scaffolding
proteins were enriched in the PSD preparation. Other
groups of proteins with various functions, such as
cytoskeleton-associated proteins, protein kinases and phos-
phatases, components and regulators of signaling path-
ways, and proteins involved in energy production may be
associated with multiple organelles and multiprotein
complexes, and these were consequently, as groups,
enriched in the PSD fraction to a lesser extent. Mitochon-
drial proteins and transporters were generally strongly
depleted, indicating that they were likely contaminants of
the PSD preparation.
Pre-synaptic compartment
A proteomic analysis of the synaptic vesicle identified 36
proteins, including seven integral membrane proteins and
vesicle regulatory proteins [13]. Unlike synaptic vesicle, it
is technically difficult to obtain a pre-synaptic membrane
preparation. In one study, monoclonal antibodies were used
to purify two synaptic vesicle-containing fractions from a
synaptosome preparation, and 72 proteins were identified
from the free vesicle and 81 proteins in the plasma
membrane-containing fraction [14]. It was concluded that
the latter fraction contained synaptic vesicle proteins,
components of the pre-synaptic fusion and retrieval
machinery and other proteins potentially involved in
regulating the functional and structural dynamics of the
nerve terminal. In another study, a presynaptic particle
fraction and PSD was obtained by sequential extraction of
synaptosome in Triton X-100 firstly at pH 6 and then pH 8
[11]. The presynaptic particle fraction contained a high
representation of proteins that reside in, or mediate the
trafficking of, the intracellular compartment as well as
signaling molecules.
Synaptic proteome
Several hundred to a thousand proteins have been
identified from synaptosome preparations [15, 16]. Curi-
ously, the number of proteins characterized from PSD [7]
is larger than that from synaptosome. As PSD is a
subdomain of synaptosome, it must be concluded that the
lower number of proteins identified from the synaptosome
proteomics studies is most likely due to methodological
differences. The use of more starting material and a more
extensive separation of tryptic peptides before MS/MS will
increase the number of synaptic proteins identified.
Synaptic phosphoproteome
Large-scale phosphoproteome analyses have been carried
out on synaptosome and PSD preparation. In 2005, a study
used IMAC for the enrichment of both phosphoproteins
and phosphopeptides from a synaptosome extract, fol-
lowed by LC–MS/MS analysis. This study reported the
identification of 288 phosphorylation sites, representing 79
synaptic proteins [9].
Recently, nearly 1000 phosphorylated peptides from 287
proteins were identified from PSD preparation [7].
Notably, the phosphorylation sites of glutamate receptor
subunits were also detected. Interestingly, this study
followed a conventional approach for the analysis of
phosphopeptides; i.e. sequential separation of peptides
with ion exchange chromatography, IMAC and reversed-
phase liquid chromatography, followed by MS/MS analy-
sis. The success of this study relied on the maximization of
the separation of the peptides through the use of a large
number of fractions collected from cation exchange
chromatography and the detailed analysis of each fraction
by LC–MS/MS.
Quantitative synaptic proteomics
Performing quantitative proteomics is a challenging task,
and only a few studies have been reported. In one study,
ICAT reagents were used to study the alteration of synaptic
membrane proteins after chronic morphine administration,
and this revealed changes in several synaptic plasma
membrane proteins [17]. In another study, both ICAT
reagents and AQUA peptides were used for the comparative
analysis of PSD isolated from forebrain and cerebellum [5].
Currently, we are using iTRAQ reagents to examine the
differences in the expression patterns of synaptic mem-
brane proteins in the hippocampi of wild-type and various
mutant mice that have well-defined behavioral abnormal-
ities [18]. In a typical study it is possible to assign 1000–
1500 protein clusters (non-redundant protein sequences).
For quantitative purposes we only consider proteins that
are matched with at least three peptides with the highest CI
% of a peptide (>95%). Generally, 300–600 proteins can be
quantified. In a mutant mouse for which the mRNA of
calcium/calmodulin-dependent protein kinase II α cannot
be targeted to the synapse and therefore cannot be
synthesized de novo locally, we detected a 70% decrease
in this kinase in the synaptic membrane of hippocampus.
Finally, a first draft of a synaptic protein interaction
network has been constructed using commercial available
software—Ingenuity Pathways Analysis—and the synaptic
proteins have been organized into 13 (interconnecting)
functional groups belonging to the pre- and post-synaptic
compartments, including receptors and ion channels,
scaffolding proteins, cytoskeletal proteins, signaling pro-
teins, adhesion molecules, and proteins of synaptic vesicles
as well as those involved in membrane recycling.
Outlook
Synapse proteome studies have produced a wealth of
qualitative data so far. In the near future, quantitative
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models will need to be constructed in order to explain how
a complex protein network drives synaptic functions in the
brain. In order to generate experimental data and to
construct models in a concerted manner, it is important to
iterate between system analysis, model construction and
system prediction. Quantitative synaptic proteomics de-
scribing the changes in synapse proteome in response to
environmental, genetic and/or pharmacological perturba-
tions will be fed into the models for adjustment purposes,
and to identify new elements to test during a new round of
experiments. I foresee that bioinformatics will play a major
role when analyzing the vast number of datasets involved,
and when constructing and testing the models.
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